These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28662514)
1. Emodin: One Main Ingredient of Shufeng Jiedu Capsule Reverses Chemoresistance of Lung Cancer Cells Through Inhibition of EMT. Ying Y; Qingwu L; Mingming X; Zhenju S; Chaoyang T; Zhengang T Cell Physiol Biochem; 2017; 42(3):1063-1072. PubMed ID: 28662514 [TBL] [Abstract][Full Text] [Related]
2. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma. Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492 [TBL] [Abstract][Full Text] [Related]
3. Camel Urine Promotes Sensitization to Doxorubicin by Inhibiting Epithelial-Mesenchymal Transition and Modulating NF-κB-Snail Signaling Pathway in Breast Cancer Cells. Al-Mutairi MS; Matar IK; Alfadli S; Al-Mutairi A Asian Pac J Cancer Prev; 2021 Dec; 22(12):4017-4029. PubMed ID: 34967584 [TBL] [Abstract][Full Text] [Related]
4. The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell. Teng X; Wang SY; Shi YQ; Fan XF; Liu S; Xing Y; Guo YY; Dong M Anticancer Drugs; 2021 Oct; 32(9):939-949. PubMed ID: 34001704 [TBL] [Abstract][Full Text] [Related]
5. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway. Zhou P; Wang C; Hu Z; Chen W; Qi W; Li A BMC Cancer; 2017 Dec; 17(1):813. PubMed ID: 29202800 [TBL] [Abstract][Full Text] [Related]
6. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3 Lu J; Xu Y; Wei X; Zhao Z; Xue J; Liu P Biomed Res Int; 2016; 2016():6253280. PubMed ID: 28097141 [TBL] [Abstract][Full Text] [Related]
7. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis. Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway. Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270 [TBL] [Abstract][Full Text] [Related]
10. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling. Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271 [TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway. Tong J; Shen Y; Zhang Z; Hu Y; Zhang X; Han L Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967496 [TBL] [Abstract][Full Text] [Related]
12. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Chang TH; Tsai MF; Su KY; Wu SG; Huang CP; Yu SL; Yu YL; Lan CC; Yang CH; Lin SB; Wu CP; Shih JY; Yang PC Am J Respir Crit Care Med; 2011 Apr; 183(8):1071-9. PubMed ID: 21037017 [TBL] [Abstract][Full Text] [Related]
13. MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc. Tao L; Shu-Ling W; Jing-Bo H; Ying Z; Rong H; Xiang-Qun L; Wen-Jie C; Lin-Fu Z Biomed Pharmacother; 2020 May; 125():109962. PubMed ID: 32106373 [TBL] [Abstract][Full Text] [Related]
14. The Effect of TIGAR Knockdown on Apoptotic and Epithelial-Mesenchymal Markers Expression in Doxorubicin-Resistant Non-Small Cell Lung Cancer A549 Cell Lines. Agca CA; Kırıcı M; Nedzvetsky VS; Gundogdu R; Tykhomyrov AA Chem Biodivers; 2020 Sep; 17(9):e2000441. PubMed ID: 32639659 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype. Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
17. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells. Feng H; Lu JJ; Wang Y; Pei L; Chen X Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373 [TBL] [Abstract][Full Text] [Related]
18. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation. Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor SAHA-induced epithelial-mesenchymal transition by upregulating Slug in lung cancer cells. Wang J; Xu MQ; Jiang XL; Mei XY; Liu XG Anticancer Drugs; 2018 Jan; 29(1):80-88. PubMed ID: 29176396 [TBL] [Abstract][Full Text] [Related]
20. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways. Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]